


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
IRD
Opus Genetics Inc.
$2.12
Strengths

Upgraded on attractively valued
IRD Price Performance
$2.27 (-6.61%)
$2.05 (+3.41%)
$1.2 (+76.67%)
$1.2 (+76.67%)
IRD has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

IRD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
IRD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRD Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is IRD current stock price?
What are IRD stock strengths?
What is IRD Risk Level?
What is IRD market cap and volume?
What is IRD current Stock IQ?
Should I buy IRD stock right now?
Is IRD a Strong Buy right now?
What does a 'Strong Buy' rating mean for IRD?
What does a 'Strong Sell' rating mean for IRD?
What factors influence IRD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
IRD
Opus Genetics Inc.
Current Price
$2.12
Stock Insights
Strengths

Upgraded on attractively valued

IRD Price Performance
$2.27 (-6.61%)
$2.05 (+3.41%)
$1.2 (+76.67%)
$1.2 (+76.67%)
IRD Analysts Opinion
IRD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
IRD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRD Street Sentiment is extremely bullish and have negative views on the near-term outlook
IRD has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
IRD Stock IQ
IRD Latest Analysis
Hedge Fund and Insider Trading News: Ken Griffin Warren Buffett Bridgewater Associates AQR Capital Management Schonfeld Strategic Advisors D.E. Shaw Millennium Management Elliott Management Discovery Capital Management Opus Genetics Inc (IRD) Burcon NutraScience Corp (BU) and More. Ken Griffins Flagship Hedge Fund At Citadel Rises 10.2% In Volatile 2025 (CNBC) Warren Buffett Has Retired. Could His Investing Approach Still Work Today? () Bridgewater D.E. Shaw Among Top Hedge Fund Gainers Of 2025
Fri Jan 2, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.